Benztropine 0.5 mg Tablets — Generic For Cogentin — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Benztropine mesylate tablets are an oral medicine available in 0.5 mg, 1 mg, and 2 mg strengths. The label says the tablets are used as an adjunct in the therapy of all forms of parkinsonism.

The tablets are also used to help control extrapyramidal disorders caused by neuroleptic drugs, such as phenothiazines, except for tardive dyskinesia. The label notes that the medicine has anticholinergic effects, and that these are the effects considered therapeutically significant for parkinsonism.

The label lists important warnings and precautions, including possible drowsiness or impaired ability to do hazardous tasks, and the need to watch for heat-related problems, urinary retention, confusion, hallucinations, and glaucoma concerns. It also states that use in pregnancy has not been established and that the product should be used with caution in children over 3 years of age.

Storage Information

Store at 20° to 25° C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in well-closed containers as defined in the USP.

Key Counseling Points

• This medicine is taken by mouth and is used for parkinsonism and some drug-induced movement disorders.
• Do not use it for tardive dyskinesia; the label says antiparkinsonism agents do not relieve it and may worsen it.
• It may cause confusion, hallucinations, or other mental changes, especially at higher doses or in susceptible patients.
• It may cause dry mouth, blurred vision, constipation, nausea, or vomiting.
• Tell a clinician promptly about trouble urinating, urinary retention, or painful urination.
• The label warns about heat intolerance, decreased sweating, hyperthermia, and heat stroke; report fever or heat-related symptoms promptly.
• This medicine may impair the ability to drive or operate machinery.
• Do not stop other antiparkinsonian medicines abruptly when benztropine is started; the label says changes should be gradual.
• Use caution if there is glaucoma, especially angle-closure glaucoma, or a tendency to fast heart rate.
• Keep this medicine out of reach of children.

Helpful Patient Education

Benztropine mesylate tablets, USP are an oral prescription medicine available in 0.5 mg, 1 mg, and 2 mg strengths. According to the label, they are used as an adjunct therapy for all forms of parkinsonism and for certain extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

This product information includes key safety details such as possible dry mouth, blurred vision, constipation, urinary retention, confusion, hallucinations, and heat-related adverse effects. The label also notes caution with tasks requiring alertness, as well as important precautions related to glaucoma, pregnancy, and pediatric use.

Medication Summary last generated: 2026-07-17 02:54:10